Category: Oncotarget

Oncotarget News

Oncotarget

Behind the Study: Statins Primary Mode of Action Against Cancer Cells

February 15, 2021

Neuro-oncologist physician-scientist Dr. Benjamin Purow describes the findings in a paper he helped author in Oncotarget titled, "Statins affect human glioblastoma and other cancers through TGF-β inhibition."The Behind... read more

Oncotarget

Special Collections by Oncotarget: Prostate Cancer

February 11, 2021

Prostate cancer, or prostatic carcinoma, occurs in a small walnut-shaped gland in males that is responsible for producing the seminal fluid which nourishes and transports sperm—the prostate. Symptoms of... read more

Oncotarget

Behind the Study: Critical Role STAT3 Plays in Glioma-initiating Cells

February 8, 2021

The head chair of pathology and a graduate research assistant from the University of Tennessee Health Science Center detail their paper published in Oncotarget titled, "The critical role that STAT3... read more

Oncotarget

Behind the Study: Metronomic Cyclophosphamide – Innate Immunity and Anti-Tumor Responses

February 1, 2021

Researcher Mary Janatpour describes the findings in a paper she helped author in Oncotarget titled, "Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate... read more

Oncotarget

Behind the Study: Empty SV40 Capsids Elicit Host Signaling Networks

January 25, 2021

Researcher Arieh Eden discusses a recent paper published in Oncotarget entitled, "Empty SV40 capsids increase survival of septic rats by eliciting numerous host signaling networks that participate in a number... read more

Oncotarget

Special Collection by Oncotarget: Lung Cancer

December 11, 2020

Lung cancer is still the leading cause of cancer-related mortality worldwide. According to the CDC, smoking cigarettes is linked to 80-90% of lung cancer deaths in the United States. In... read more

Special collection on breast cancer graphic image

Oncotarget

Oncotarget’s Special Collection on Breast Cancer

November 12, 2020

As you may know, Oncotarget is a scientific journal that publishes oncology-focused review and research papers bi-weekly on its open access platform — available at no cost to readers. Recently, a... read more

Oncotarget

Then Vs. Now: Celebrating 25 Years of the Ride

November 12, 2020

During the inaugural Ride for Roswell back on June 29, 1996, 986 riders helped raise $101K in the fight against cancer. During the Summer of the Ride of 2020, more... read more

Oncotarget

By the Numbers: Ride for Roswell

November 12, 2020

Behind the thousands of riders and millions raised to fight cancer during the history of the Ride for Roswell, there are many facts and figures you may not be aware... read more

Oncotarget

Timeline: 25 Years of the Ride and Introduction of Impact Journals

November 12, 2020

Throughout the 25-year history of the Ride for Roswell, there have been many milestones and celebrations along the way. From June 29, 1996 through the Summer of the Ride during... read more